Modified polynucleotides for the production of biologics and proteins associated with human disease
US-8999380-B2 · Apr 7, 2015 · US
US12109274B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12109274-B2 |
| Application number | US-201615760686-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 19, 2016 |
| Priority date | Sep 17, 2015 |
| Publication date | Oct 8, 2024 |
| Grant date | Oct 8, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention features polynucleotides encoding a polypeptide including a 3′-stabilizing region and having increased stability compared to wild-type polynucleotides.
Opening claim text (preview).
What is claimed: 1. A polynucleotide encoding a polypeptide, wherein said polynucleotide comprises: (a) a 5′-cap structure; (b) a 5′-UTR; (c) a coding region encoding the polypeptide; (d) a 3′-UTR; and (e) a 3′-stabilizing region comprising 1 to 500 nucleosides, wherein one or more of said nucleosides is an inverted thymidine. 2. The polynucleotide of claim 1 , wherein said polynucleotide further comprises (f) a poly-A region. 3. The polynucleotide of claim 1 , wherein said stabilizing region comprises at least two different nucleosides. 4. The polynucleotide of claim 1 , wherein said stabilizing region comprises 10 nucleosides. 5. The polynucleotide of claim 1 , wherein the 3′-stabilizing region comprises a 5′-terminus, wherein said 5′-terminus of said 3′-stabilizing region is conjugated to the 3′-terminus of said poly-A region. 6. The polynucleotide of claim 1 , wherein said polynucleotide comprises a 3′-terminus, wherein said 3′-stabilizing region comprises said 3′-terminus of said polynucleotide. 7. The polynucleotide of claim 2 , wherein said poly-A region comprises at least one alternative nucleoside. 8. The polynucleotide of claim 3 , wherein at least one nucleoside is 2′-O-methyl-adenosine. 9. The polynucleotide of claim 8 , wherein said stabilizing region comprises the structure: or a salt thereof; wherein each X is, independently O or S; and A represents adenine and T represents thymine.
General methods for enhancing the expression · CPC title
with ribosyl as saccharide radical · CPC title
at least one of the hetero rings does not contain nitrogen as ring hetero atom · CPC title
containing the ring system [IMAGE cpc-sch-C07F-1006.gif] having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs · CPC title
Manipulation of the nucleic acid to modify its expression pattern, e.g. enhance its duration of expression, achieved by the presence of particular introns in the delivered nucleic acid · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.